231 related articles for article (PubMed ID: 36270494)
1. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
[TBL] [Abstract][Full Text] [Related]
2. Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial.
Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Patsiou V; Bekiaridou A; Baroutidou A; Tsagkaris C; Karagiannidis E; Daios S; Anastasiou V; Tsalikakis D; Efthimiadis G; Ziakas A; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol; 2023 Mar; 81(3):203-211. PubMed ID: 36626410
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
4. Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure Registry.
Schrage B; Lund LH; Benson L; Braunschweig F; Ferreira JP; Dahlström U; Metra M; Rosano GMC; Savarese G
Eur J Heart Fail; 2023 Jul; 25(7):1132-1144. PubMed ID: 37317585
[TBL] [Abstract][Full Text] [Related]
5. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
[TBL] [Abstract][Full Text] [Related]
6. Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients.
Takeuchi S; Kohno T; Goda A; Shiraishi Y; Kawana M; Saji M; Nagatomo Y; Nishihata Y; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
ESC Heart Fail; 2022 Aug; 9(4):2500-2510. PubMed ID: 35561100
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of guideline-directed medical therapy in patients with heart failure on regular hemodialysis.
Kishihara M; Takada T; Jujo K; Shirotani S; Abe T; Yoshida A; Watanabe S; Hagiwara N
Int J Cardiol; 2023 Jan; 370():250-254. PubMed ID: 36270495
[TBL] [Abstract][Full Text] [Related]
8. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
9. Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction.
Chen X; Cui X; Thunström E; Pivodic A; Dahlström U; Fu M
Clin Res Cardiol; 2021 Jul; 110(7):1051-1062. PubMed ID: 33394127
[TBL] [Abstract][Full Text] [Related]
10. Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum.
Chen X; Kang Y; Dahlström U; Fu M
ESC Heart Fail; 2023 Dec; 10(6):3656-3666. PubMed ID: 37803813
[TBL] [Abstract][Full Text] [Related]
11. Impact of guideline-directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta-analysis.
Li J; Chen Y; Wang Y; Liu X; Li P; He Y; Hao Y; Huang L; Jin J; Wang J; Anderson C
Eur J Heart Fail; 2024 Jun; 26(6):1435-1442. PubMed ID: 38606573
[TBL] [Abstract][Full Text] [Related]
12. Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
Harikrishnan S; Jeemon P; Ganapathi S; Agarwal A; Viswanathan S; Sreedharan M; Vijayaraghavan G; Bahuleyan CG; Biju R; Nair T; Pratapkumar N; Krishnakumar K; Rajalekshmi N; Suresh K; Huffman MD
Int J Cardiol; 2021 Mar; 326():139-143. PubMed ID: 33049297
[TBL] [Abstract][Full Text] [Related]
13. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
[TBL] [Abstract][Full Text] [Related]
14. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
ESC Heart Fail; 2023 Feb; 10(1):223-233. PubMed ID: 36193578
[TBL] [Abstract][Full Text] [Related]
15. Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure.
Veenis JF; Brunner-La Rocca HP; Linssen GCM; Van Gent MWF; Hoes AW; Brugts JJ;
Circ Heart Fail; 2020 May; 13(5):e006667. PubMed ID: 32370547
[TBL] [Abstract][Full Text] [Related]
16. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.
Lainščak M; Milinković I; Polovina M; Crespo-Leiro MG; Lund LH; Anker SD; Laroche C; Ferrari R; Coats AJS; McDonagh T; Filippatos G; Maggioni AP; Piepoli MF; Rosano GMC; Ruschitzka F; Simić D; Ašanin M; Eicher JC; Yilmaz MB; Seferović PM;
Eur J Heart Fail; 2020 Jan; 22(1):92-102. PubMed ID: 31863522
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry.
Harikrishnan S; Bahl A; Roy A; Mishra A; Prajapati J; Manjunath CN; Sethi R; Guha S; Satheesh S; Dhaliwal RS; Sarma M; Ganapathy S; Jeemon P;
ESC Heart Fail; 2022 Dec; 9(6):3898-3908. PubMed ID: 36214477
[TBL] [Abstract][Full Text] [Related]
18. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of additional mineralocorticoid receptor antagonists in octogenarian heart failure patients.
Abe T; Jujo K; Kametani M; Minami Y; Fukushima N; Saito K; Hagiwara N
ESC Heart Fail; 2020 Oct; 7(5):2711-2724. PubMed ID: 32860346
[TBL] [Abstract][Full Text] [Related]
20. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction.
Mefford MT; Koyama SY; De Jesus J; Wei R; Fischer H; Harrison TN; Woo P; Reynolds K
J Am Heart Assoc; 2022 Apr; 11(7):e023766. PubMed ID: 35322672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
